|
New publication
|
11
|
Resverlogix Corp.
|
Sep 21, 2019 05:39PM
|
|
New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
2
|
Zenith Epigenetics
|
Jun 13, 2016 04:27PM
|
|
New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
4
|
Resverlogix Corp.
|
Jun 13, 2016 04:30PM
|
|
New publications
|
7
|
Resverlogix Corp.
|
Oct 08, 2015 02:46PM
|
|
New Published Evidence of Apabetalone’s Beneficial Effects on COVID-19
|
4
|
Resverlogix Corp.
|
Mar 03, 2021 02:28PM
|
|
New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
7
|
Resverlogix Corp.
|
May 11, 2016 02:30PM
|
|
New RVX Blog 9/22/16: RESVERLOGIX’S POSTER PRESENTATION AND EVIDEO FROM THE EASD
|
8
|
Resverlogix Corp.
|
Sep 22, 2016 12:13PM
|
|
New RVX Blog Post: Balancing Epigenetics in the Treatment of Chronic Kidney Disease
|
3
|
Resverlogix Corp.
|
Sep 13, 2019 02:39PM
|
|
New RVX Publication in Atherosclerosis
|
12
|
Resverlogix Corp.
|
Jan 23, 2016 11:07PM
|
|
New RVX-208 paper on downregulation of the complement cascade
|
4
|
Resverlogix Corp.
|
Jun 01, 2017 01:49PM
|
|
New Trial: Continuation Protocol for ZEN003694 in mCRPC Patients
|
11
|
Zenith Epigenetics
|
Oct 30, 2019 11:17AM
|
|
New version of May slide deck and ERA-EDTA Conference & Symposium
|
3
|
Resverlogix Corp.
|
May 18, 2018 11:40AM
|
|
New Video on Lysosomal Storage Disease Scarpa Study from BTI
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 06, 2015 08:39AM
|
|
New Video on Perception and Memory
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2017 01:32PM
|
|
New website
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 09, 2017 09:10PM
|
|
New Zacks SCR report "Apabetalone: A Potential Alzheimer's Play?"
|
7
|
Resverlogix Corp.
|
Aug 24, 2018 10:08AM
|
|
New Zealand Renal Phase 1 Trial with RVX-208
|
4
|
Resverlogix Corp.
|
Jun 17, 2016 12:45PM
|
|
New Zenith Clinical Trial Listing: ZEN003694 and Nivolumab w/ or w/o Ipilimumab in Solid Tumors
|
10
|
Zenith Epigenetics
|
Apr 23, 2021 08:04AM
|
|
New Zenith Drug ZEN-3365 Publication
|
3
|
Zenith Epigenetics
|
Aug 04, 2021 12:08PM
|
|
New Zenith immuno-oncology trial with Keytruda
|
4
|
Zenith Epigenetics
|
Oct 25, 2019 09:29AM
|
